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Abstract: Objective: The aim of this study was to assess antimicrobial stewardship activities
in Community Healthcare Organisations (CHOs) with focus on the implementation of the two
national antimicrobial stewardship toolkits, TARGET (Treat Antibiotics Responsibly, Guidance,
Education, Tools) and SSTF (Start Smart, then Focus). The study utilised a web-based survey
comprising 34 questions concerning antimicrobial policies and awareness and implementation of
antimicrobial stewardship toolkits. This was distributed to pharmacy teams in all 26 CHOs in
England. Twenty CHOs (77%) responded. An antimicrobial stewardship (AMS) committee was
active in 50% of CHOs; 25% employed a substantive pharmacist post and 70% had a local antibiotic
policy. Fourteen of the responding CHOs were aware of both AMS toolkits, five organisations were
aware of either SSTF or TARGET, and one organisation was not aware of either toolkit. Of the
organisations aware of SSTF and TARGET, eight had formally reviewed both toolkits, though three
had not reviewed either. Less than half of the respondents had developed local action plans for
either toolkit. National guidance in England has focused attention on initiatives to improve AMS
implementation in primary and secondary care; more work is required to embed AMS activities and
the implementation of national AMS toolkit recommendations within CHOs.
Keywords: antibiotics; community hospitals; community health trusts; start smart then focus;
general practice; TARGET toolkit
1. Introduction
Antimicrobial resistance (AMR) poses a serious threat to global public health with clinical and
economic implications. Antibiotic-resistant bacterial infections are associated with increased mortality
compared to those without resistance [1]. The overuse and inappropriate use of antimicrobials is
recognised as the major driver for the development of AMR [2].
Antimicrobial stewardship (AMS) programmes encourage the responsible use of antimicrobials
through the delivery of multiple evidence-based interventions. Studies demonstrate that AMS
interventions reduce excessive antibiotic prescribing in secondary care, can reduce AMR and healthcare
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associated infections (HCAIs), increase effective prescribing, and improve clinical outcomes for
patients [3]. AMS programmes are increasingly regarded as essential to tackling AMR and safeguarding
human health [4,5].
In 2013, a cross-government five-year strategy was published to tackle AMR in the UK. A key
aim of this strategy was to optimise prescribing practice through the implementation of AMS
programmes [6]. Two national evidence-based AMS toolkits are currently available for use by
healthcare organisations in England: Start Smart, then Focus (SSTF) [7] and Treat Antibiotics
Responsibly, Guidance, Education, Tools (TARGET) [8] for secondary and primary care, respectively.
SSTF was produced by Public Health England (PHE) in 2011 and updated in 2015. It recommends
prompt antibiotic treatment for hospital inpatients using local guidance based on local resistance
patterns; advises on the documentation of route, indication, dose, duration, and 48–72 h review
after initiation of antibiotic therapy; and recommends routine audits to assess adherence to AMS
principles. TARGET was produced by PHE in collaboration with the Royal College of General
Practitioners in 2012. The toolkit provides guidance to help general practice decide when and what
antibiotics to prescribe and tools such as patient leaflets to share during consultations, as well as
educational and audit materials. The implementation of these toolkits and associated audits is a
criterion within the “Health and Social Care Act 2008: Code of Practice on prevention and control of
infections” [9]. In addition, they are recommended as part of the National Institute for Health and
Care Excellence (NICE) guidance on AMS [10]. We have previously conducted studies to assess the
implementation of these toolkits in primary care (general practice) and secondary care (acute care
hospitals) [11]. Both toolkits are also available for use in Community Healthcare Organisations (CHOs).
However, a gap currently exists in the knowledge of antimicrobial use and AMS activities in this
setting. CHOs are specialist organisations that provide community-based health services for adults
and children, such as district nursing (including out-of-hours nursing), health visiting, school nursing,
physiotherapy, speech and language therapy, and podiatry.
Surveillance data from 2014 showed that 74% of the antibiotics prescribed in England were in
general practice (primary care), 18% were prescribed for patients in secondary care, 5% for patients
in dental practices, and 3% for patients in community organisations [12]. Though prescribing within
CHO settings accounts for a relatively small proportion, this setting represents an important sector
within healthcare delivery.
The aim of this study was to gain an understanding of AMS activities in the community health
setting with respect to the implementation of the two national AMS toolkits and to highlight where
improvements may be required.
2. Results
Twenty CHOs (77%) out of the 26 CHOs in England responded to the survey; there were
responsible for managing 93 hospitals overall and serving a total population of nearly 28 million
(according to population data reported within individual CHO publications). The responding CHOs
were broadly located in three geographical regions: The West and North West of England (ten CHOs
covering a population of nearly 15.3 million); the East of England (two CHOs covering a population of
around 4 million); and London, the South East and the south coast (seven CHOs covering 7.8 million).
See Figure 1 for a map showing the geographical regions served by CHOs that responded to the survey.
Ten percent (2/20) of CHOs had 10–50 beds, 20% (4/20) had 51–100 beds, 10% (2/20) had 101–200
beds, and 60% (12/20) had >200 beds. Sixty percent (12/20) of CHOs had beds for use as inpatient
step-up (patients admitted from home as an alternative to acute hospital admission), 85% (17/20)
had beds for inpatient step-down (patients transferred from acute hospital, for people who require
additional time and rehabilitation to recover but are unable to have this provided at home), and 40%
had beds (8/20) for mental healthcare. The services provided by the majority of responding community
health service organisations included dentistry, palliative care, physiotherapy, podiatry, rehabilitation,
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sexual health, learning disabilities services, and minor injury and illness centres and services for
older adults.Antibiotics 2018, 7, x 3 of 10 
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2.1. Implementation of National Toolkits
Eighteen (90%) of the responding CHOs indicated that they were aware of the primary care toolkit,
TARGET, and fifteen (75%) were aware of the secondary care toolkit, SSTF. One organisation was not
aware of either toolkit and fourteen were aware of both. The AMS national toolkit implementation
and other AMS activities reported by the CHOs are summarised in Table 1.
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Table 1. Summary of antimicrobial stewardship activities and the implementation of national toolkits.
AMS Actions Number (%) of CHOs (N = 20 CHOs Total)
AMS activities:
AMS committee active 10 (50%)
AMS pharmacist on site 5 (25%)
Grade of AMS pharmacy team:
Pharmacy technician—band 4 or 5 0 (0%)
Pharmacist—band 7 1 (5%)
Pharmacist—band 8a 3 (15%)
Pharmacist—band 8b 1 (5%)
Remaining pharmacist posts 0 (0%)
Antibiotic policies in place:
Antimicrobial formulary 17 (85%)
Empirical antibiotic guidelines 11 (55%)
Restricted antibiotic list 2 (10%)
Intravenous to oral switch 3 (15%)
Surgical antimicrobial prophylaxis 2 (10%)
Automatic stop 3 (15%)
Separate antimicrobial drug chart/section 3 (15%)
Outpatient parenteral therapy (OPAT) 10 (50%)
Awareness and implementation of AMS national toolkits:
TARGET: SSTF:
Awareness of toolkit 18 (90%) 15 (75%)
Toolkit formally reviewed 11 (55%) 10 (50%)
Toolkit-recommended audits implemented 10 (50%) 15 (75%)
Toolkit action plan in place 7 (35%) 8 (40%)
2.2. Informal/Formal Review and Implementation of the TARGET or SSTF Toolkits between CHOs
Sixteen CHOs were both aware of the TARGET toolkit and had either formally or informally
reviewed it. Of these, seven (44%) had action plans in place and ten (62.5%) had implemented audits.
By comparison, the two CHOs that were aware of the TARGET toolkit but had not reviewed it
(formally or informally) had neither implemented audits nor put action plans in place. In terms of the
SSTF toolkit, all CHOs that were aware of the toolkit had also either formally or informally reviewed
the toolkit. Of those CHOs aware of both toolkits (n = 14), over one third had written action plans in
place (5/14) and eight (57%) had formally reviewed both toolkits. Eight CHOs had also implemented
suggested audits.
2.3. Implementation of both TARGET and SSTF Toolkits Across CHOs with Varying Bed Numbers and Bed Types
The implementation of the TARGET and SSTF toolkits amongst CHOs that were aware of the
toolkits was compared according to CHO characteristics: bed number and bed type (Figure 2). Six of
the ten CHOs with >200 beds had audits implemented for both SSTF and TARGET (60%); all ten had
audits implemented for at least one. For the four CHOs with <200 beds, implementation of audits
for both SSTF and TARGET was 50% and implementation of at least one was 75%. The five CHOs
with written action plans in place for both toolkits all had >200 beds. Five further CHOs did not have
written action plans in place for either TARGET or SSTF; three were for CHOs with >200 beds and
two were for CHOs with <200 beds. The remaining three CHOs (one with 10–50 beds and two with
>200) had action plans in place for SSTF only. With respect to bed type, there was very little difference
between the numbers of those with written action plans in place or those that had audits implemented
for both/neither TARGET and SSTF toolkits (Figure 2).
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2.5. Implementation of AMS and AMR Education and Training Initiatives across CHOs
The implementation of education and training initiatives varied between the healthcare
professional groups (Table 2). In 40% of the responding CHOs, prescribers (both doctors and
non-medical prescribers) received AMS/AMR teaching at induction, and in 35% of CHOs this was
received by all staff groups. In eight out of twenty CHOs, both doctors and pharmacists received
education when starting in the organisations. There was limited access to e-learning modules. Overall,
eight CHOs provided either optional or mandatory e-learning to any professional group. In five CHOs
(25%), optional e-learning was available to all staff groups; e-learning completion was mandatory for
at least one staff group in three CHOs, and mandatory for all staff groups in only one.
Table 2. Implementation of education and training initiatives in responding CHOs.
Healthcare Professional Groups
Percentage of CHO Organisations that Provide the Following
Education and Training Initiatives to Healthcare Professionals
Doctors Nurses Pharmacist Non-Medical Prescribers
Received AMS/AMR teaching
on induction 50% 40% 50% 50%
Provided with antibiotic
guidelines on induction 75% 55% 65% 75%
Have access to optional e-learning 25% 30% 25% 30%
Need to complete mandatory
e-learning module 15% 10% 10% 10%
3. Discussion
The findings of this survey showed a variable implementation of the national AMS toolkits in
community healthcare organisations. Encouragingly, awareness of the TARGET and SSTF toolkits
was high amongst the responding CHOs (90% and 75% of the responding CHOs, respectively) and 16
CHOS (80%) had either informally or formally reviewed either toolkit. This level was similar to that
seen previously in secondary care acute trusts (87%) [11]. However, implementation of both toolkits
(for instance formal review and implemented audits) was evident in under half of CHOs. Work in
primary and secondary care found that having formally or informally reviewed AMS toolkits was
associated with the development of action plans or the implementation of the toolkits [11]. This may
also be the case in the current study. Two trusts without formal/informal review of the TARGET toolkit
had also not implemented this toolkit, whereas implementation was evident (in the form of written
action plans or implemented audits) for ~40–60% of CHOs who had reviewed the TARGET toolkit.
Whether a formal/informal review of the SSTF toolkit led to toolkit implementation was impossible
to ascertain.
There was little evidence to determine conclusively whether the implementation of either toolkit
was influenced by CHO size or characteristics (the number of beds and bed type), although, in general,
the level of implementation appeared higher amongst CHOs with over 200 beds.
Previous work has highlighted the potential importance of specialist antimicrobial pharmacists
in delivering AMS activities [11]. However, only 25% of the responding CHOs had such a post.
Whilst this figure was greater than that in primary care organisations (5%), it was much lower than
that in secondary care (94%) [11]. In comparison to primary and secondary healthcare organisations,
dedicated antimicrobial policies were only in place in 70% of the CHOs (99% and 93% in primary and
secondary care, respectively). Equally, a lower proportion of CHOs (55%) had empirical antibiotic
guidelines compared to primary care (73%) and secondary care trusts (83%). An AMS committee
was active in 50% of the CHOs compared to 18% in primary care and 94% in secondary care [11].
Further research is evidently necessary to establish the relationship between the presence of AMS
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committees and/or dedicated AMS posts and the implementation of AMS toolkits, particularly in the
CHO setting.
The results also showed that there was inadequate AMR/AMS education and training provided
in CHOs. Half of the CHOs provided AMR/AMS teaching on induction to doctors, though only 40%
provided this to both doctors and non-medical prescribers and 25% of the CHOs provided AMR/AMS
induction training to all staff groups. The more frequent provision of AMS training to doctors and
pharmacists compared to nurses and all other staff groups was also seen in secondary care [11] and
reflects a pattern seen worldwide [13]. The code of practice states that all prescribers should receive
AMR/AMS teaching on induction [9]. The improvement of ”professional education, training and
public engagement” is also one of the seven key areas within the UK five-year AMR strategy [6],
highlighting the importance of this area. Further effort is therefore required to promote delivery of
AMS in CHOs; education and training can play an important role in helping to achieve this. With very
limited specialist antimicrobial pharmacists in CHOs, regional medicines optimisation committees,
NHS England/Improvement and PHE will need to work through senior pharmacists as well as medical
and nursing directors to improve AMS activities in these settings. This could include promotion of
the Health Education England introductory AMR e-learning module [14] and adaptation of the
antimicrobial stewardship surveillance tools for use in community health organisations. In a similar
way to primary and secondary care, it will be important to consider collation, analysis, and publication
of antimicrobial consumption data in these settings to monitor the progress on improving prudent
antibiotic use.
Previous work has noted that the AMS focus on and audits relating to the ”start smart” aspects
of SSTF were more common than those relating to “then focus” [11,15]. Further research would be
helpful to look more in-depth at the implementation of AMS audits in CHO settings, i.e., data that was
not captured in the current survey.
The major limitation of this study is that data were self-reported by pharmacists practising in
CHOs; the authors could not verify that the reported AMS activities were actually taking place. Due to
the low numbers, it was also difficult to assess the factors affecting successful implementation of the
AMS toolkits.
A collaborative cross-sector approach to the delivery of AMS is in line with a move towards
integrated care and is likely important in terms of optimising antibiotic usage across the healthcare
system [11,16]. A health-system-wide perspective is also inherent to the national guidance on AMS [8].
Such collaboration between primary and secondary care in the UK has already been noted [9]. Given the
cross-cutting position of CHOs within the healthcare sector, embedding of successful AMS strategies
and toolkits in CHO settings will likely play a key role in promoting system-wide optimal antibiotic
use. This highlights the importance of assessing AMS strategies within the CHO setting. To our
knowledge, the current study is the first to do this. Further research will be necessary to assess,
in greater depth, the factors affecting the successful implementation of AMS toolkits and to identify
barriers to implementations in this setting.
4. Materials and Methods
A web-based cross-sectional survey based on previous studies for primary care and acute care
organisations was developed using SelectSurvey. Six pharmacists working in Community Health
Organisations (CHOs) piloted the survey in October 2015. The survey was subsequently revised
and sent out to all representing CHOs in England during February 2016 using the community health
services pharmacists’ network. The survey consisted of 50 items. In addition to general demographic
questions and CHO information, the questions covered antimicrobial policies and guidance and
prescribing support; the presence of AMS-dedicated staff posts and committees; awareness,
implementation, and audit of AMS toolkits; and education in antimicrobial prescribing/stewardship.
This survey (Supplementary Materials) was a voluntary service evaluation completed by healthcare
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professionals and thus ethical approval was not required. Survey responses were analysed using
Microsoft Excel 2010 and Stata 13.
5. Conclusions
The findings of this survey showed that there was variable implementation of the national AMS
toolkits (Start Smart then Focus and TARGET) in community healthcare organisations. The results
also highlighted that the AMR/AMS education and training provided in CHOs may be inadequate.
The findings from this study along with previous studies assessing AMS activities in primary and
secondary care highlight the need for a cross-sector approach to the delivery of AMS.
Supplementary Materials: The survey tool used is available online at http://www.mdpi.com/2079-6382/7/4/
97/s1.
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